Myriad Genetics
MYGN
#6702
Rank
NZ$1.13 B
Marketcap
NZ$12.22
Share price
-0.28%
Change (1 day)
-52.06%
Change (1 year)

Myriad Genetics (MYGN) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$0.64 Billion

According to Myriad Genetics's latest financial reports the company has NZ$0.64 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Myriad Genetics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$1.24 B0.38%
2023-12-31$NZ$1.23 B-11.23%
2022-12-31$NZ$1.39 B-1.53%
2021-12-31$NZ$1.41 B
2020-06-30$NZ$1.42 B-12.12%
2019-06-30$NZ$1.61 B13.53%
2018-06-30$NZ$1.42 B35.99%
2017-06-30$NZ$1.04 B0.07%
2016-06-30$NZ$1.04 B7.46%
2015-06-30$NZ$0.97 B18.89%
2014-06-30$NZ$0.82 B-12.86%
2013-06-30$NZ$0.94 B18.88%
2012-06-30$NZ$0.79 B15.76%
2011-06-30$NZ$0.68 B-15.12%
2010-06-30$NZ$0.80 B19.02%
2009-06-30$NZ$0.67 B21.05%
2008-06-30$NZ$0.55 B26.37%
2007-06-30$NZ$0.44 B7.35%
2006-06-30$NZ$0.41 B107.92%
2005-06-30$NZ$0.19 B-26.78%
2004-06-30$NZ$0.27 B-3.52%
2003-06-30$NZ$0.28 B5.9%
2002-06-30$NZ$0.26 B-22.76%
2001-06-30$NZ$0.34 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Bio-Rad Laboratories
BIO
NZ$11.64 B 1,707.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
NZ$4.32 B 570.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
NZ$0.5 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$10.46 B 1,524.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$88.59 B 13,651.07%๐Ÿ‡บ๐Ÿ‡ธ USA